2022 Supporting a Patient-Centric Approach to Dose Optimization in Oncology: The Essential Role of Patient-Reported Outcomes (PROs) View PDF
2023 Multi-Cancer Early Detection Screening Tests: Considerations for Use of Real-World Data View PDF
2022 Expedited Development of Diagnostics for Therapies Targeting Rare Biomarkers or Indications View PDF
2021 Harmonizing the Definition and Reported of Cytokine Release Syndrome (CRS) in Immuno-Oncology Clinical Trials View PDF